UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	February 2, 2022 4:00 P.M.

Form:	S-3
CIK: 0001408443 Company Name: Milestone Pharmaceuticals Inc. File Number: 333-261049